Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$2.0 million.

  • Volitionrx's Net Cash Flow fell 266606.69% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 4630.1%. This contributed to the annual value of -$17.8 million for FY2024, which is 28107.3% down from last year.
  • According to the latest figures from Q3 2025, Volitionrx's Net Cash Flow is -$2.0 million, which was down 266606.69% from -$669448.0 recorded in Q2 2025.
  • Volitionrx's Net Cash Flow's 5-year high stood at $13.6 million during Q1 2021, with a 5-year trough of -$9.0 million in Q3 2023.
  • In the last 5 years, Volitionrx's Net Cash Flow had a median value of -$2.0 million in 2025 and averaged -$1.1 million.
  • Data for Volitionrx's Net Cash Flow shows a peak YoY increase of 35431.45% (in 2021) and a maximum YoY decrease of 436704.53% (in 2021) over the last 5 years.
  • Over the past 5 years, Volitionrx's Net Cash Flow (Quarter) stood at -$2.4 million in 2021, then plummeted by 123.58% to -$5.5 million in 2022, then soared by 281.61% to $9.9 million in 2023, then plummeted by 133.7% to -$3.3 million in 2024, then surged by 39.19% to -$2.0 million in 2025.
  • Its Net Cash Flow was -$2.0 million in Q3 2025, compared to -$669448.0 in Q2 2025 and -$632746.0 in Q1 2025.